Researchers in China showed that nanoparticles smaller than 10 nm in diameter accumulate more efficiently and penetrate more deeply in tumors relative to their larger counterparts. Their findings have significant implications for the development of nanomaterials to diagnose and treat cancer. The enhanced tumor accumulation of the ultrasmall nanoparticles may be due, at least in part, to their prolonged blood circulation time. In contrast, most nanomaterials that enter the blood are rapidly cleared by tissue-resident macrophages in the liver and spleen. Ultimately, the ability of ultrasmall nanoparticles to diffuse deep within the tumor bulk may enable the design of nanoparticles that can carry therapeutic and diagnostic agents more efficiently into tumors.